mtm laboratories raises EUR 9 million

Cancer diagnostic developer mtm (Heidelberg, Germany) raised EUR 9 million ($10.4 million) in a first closing of its series B round. Investors included HBM BioVentures; Heidelberg Innovation; and Mann...